These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23992566)

  • 21. Novel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth.
    Fallatah MM; Liu S; Sevigny MB; Zou H; Louie MC
    Cancer Lett; 2017 Nov; 408():82-91. PubMed ID: 28844711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells.
    Lu IF; Hasio AC; Hu MC; Yang FM; Su HM
    J Nutr Biochem; 2010 Jun; 21(6):512-7. PubMed ID: 19369047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
    Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
    Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer.
    Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
    Fan M; Park A; Nephew KP
    Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
    Liang JJ; Yu WL; Yang L; Xie BH; Qin KM; Yin YP; Yan JJ; Gong S; Liu TY; Zhou HB; Hong K
    Eur J Med Chem; 2022 Feb; 229():114081. PubMed ID: 34992039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha.
    Long X; Nephew KP
    J Biol Chem; 2006 Apr; 281(14):9607-15. PubMed ID: 16459337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.
    Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
    Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
    Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Janus kinase 2--a novel negative regulator of estrogen receptor α function.
    Gupta N; Grebhardt S; Mayer D
    Cell Signal; 2012 Jan; 24(1):151-61. PubMed ID: 21907792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
    Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
    J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    Nguyen Hoang AT; Hoe KL; Lee SJ
    PLoS One; 2021; 16(4):e0246264. PubMed ID: 33861751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
    Zhang X; Mukerji R; Samadi AK; Cohen MS
    BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.
    Kim KH; Kim JY; Kwak JH; Pyo S
    Phytomedicine; 2015 Aug; 22(9):820-8. PubMed ID: 26220629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner.
    Yi JM; Kwon HY; Cho JY; Lee YJ
    Biochem Biophys Res Commun; 2009 Jan; 378(4):842-6. PubMed ID: 19084502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro.
    Xiong H; Jin X; You C
    Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.